Literature DB >> 23974060

Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.

Veera Hölttä1, Paula Klemetti, Harri M Salo, Antti Koivusalo, Mikko Pakarinen, Mia Westerholm-Ormio, Kaija-Leena Kolho, Outi Vaarala.   

Abstract

OBJECTIVE: The present understanding of inflammatory bowel disease pathogenesis mainly relies on studies of adult patients. Therefore, we studied the balance between T-effector and regulatory cells in pediatric inflammatory bowel disease.
METHODS: Quantitative polymerase chain reaction and immunohistochemistry served to quantify the expression of immunological markers in mucosal biopsies and flow cytometry analysis was used in peripheral blood mononuclear cells.
RESULTS: Colonic interleukin (IL)-17+, IL-22, and IL-6 mRNA upregulation and increase in the number of colonic IL-17 cells were demonstrated in both Crohn disease (CD) and ulcerative colitis (UC). Likewise, colonic forkhead box P3 (FOXP3+) mRNA expression and the number of colonic FOXP3 cells were increased both in CD and in UC and were accompanied in CD also with increased numbers of FOXP3+CD25 High CD4 cells in peripheral blood. Ileal relation of IL-17/CD4 cells was increased only in CD.
CONCLUSIONS: We showed activation of colonic IL-17/IL-22 axis and upregulation of FOXP3 to occur both in pediatric CD and in UC, indicating shared immunological characteristics. Upregulation of IL-17 was restricted to colon in UC, but existed in the ileum and in the colon in active CD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23974060     DOI: 10.1097/MPG.0b013e3182979252

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  10 in total

1.  Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease.

Authors:  Wenyu Jiang; Jiewen Su; Xiaofei Zhang; Xiuqin Cheng; Jun Zhou; Ruihua Shi; Hongjie Zhang
Journal:  Inflamm Res       Date:  2014-08-18       Impact factor: 4.575

2.  Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.

Authors:  Yoichiro Iboshi; Kazuhiko Nakamura; Keita Fukaura; Tsutomu Iwasa; Haruei Ogino; Yorinobu Sumida; Eikichi Ihara; Hirotada Akiho; Naohiko Harada; Makoto Nakamuta
Journal:  J Gastroenterol       Date:  2016-05-13       Impact factor: 7.527

Review 3.  Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: a meta-analysis.

Authors:  Juan Li; Hao Tian; Hui-Jun Jiang; Bin Han
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 4.  Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis.

Authors:  Rebecca Rogier; Marije I Koenders; Shahla Abdollahi-Roodsaz
Journal:  J Immunol Res       Date:  2015-02-23       Impact factor: 4.818

5.  Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis.

Authors:  Linlin Chen; Yiyou Zou; Jie Peng; Fanggen Lu; Yani Yin; Fujun Li; Junwen Yang
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

6.  Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses.

Authors:  Zhaohui Xie; Yine Qu; Yanli Leng; Wenxiu Sun; Siqi Ma; Jingbo Wei; Jiangong Hu; Xiaolan Zhang
Journal:  Drug Des Devel Ther       Date:  2015-03-18       Impact factor: 4.162

7.  Serum interleukin 17 levels in patients with Crohn's disease: real life data.

Authors:  Abdurrahman Sahin; Turan Calhan; Mustafa Cengiz; Resul Kahraman; Kubra Aydin; Kamil Ozdil; May Korachi; H Mehmet Sokmen
Journal:  Dis Markers       Date:  2014-07-16       Impact factor: 3.434

8.  Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities.

Authors:  Steven X Cho; Ina Rudloff; Jason C Lao; Merrin A Pang; Rimma Goldberg; Christine B Bui; Catriona A McLean; Magdalena Stock; Tilman E Klassert; Hortense Slevogt; Niamh E Mangan; Wei Cheng; Doris Fischer; Stefan Gfroerer; Manjeet K Sandhu; Devi Ngo; Alexander Bujotzek; Laurent Lariviere; Felix Schumacher; Georg Tiefenthaler; Friederike Beker; Clare Collins; C Omar F Kamlin; Kai König; Atul Malhotra; Kenneth Tan; Christiane Theda; Alex Veldman; Andrew M Ellisdon; James C Whisstock; Philip J Berger; Claudia A Nold-Petry; Marcel F Nold
Journal:  Nat Commun       Date:  2020-11-13       Impact factor: 14.919

Review 9.  Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease.

Authors:  Eirini Giannoudaki; Siobhan Gargan; Seamus Hussey; Aideen Long; Patrick T Walsh
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

Review 10.  Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.

Authors:  Eddy Owaga; Rong-Hong Hsieh; Beatrice Mugendi; Sakhile Masuku; Chun-Kuang Shih; Jung-Su Chang
Journal:  Int J Mol Sci       Date:  2015-09-01       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.